Mitek Systems (MITK) closed the last trading session at $9.97, gaining 7.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $13.25 indicates a 32.9% upside potential.The average comprises four short-term price targets ranging from a low of $11.00 to a high of $15.00, with a standard deviation of $1.71. While the lowest estimate indicates an increase of 10.3% from the current price ...

Rayonier (RYN) closed the last trading session at $21.61, gaining 0.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $27.2 indicates a 25.9% upside potential.The average comprises five short-term price targets ranging from a low of $24.00 to a high of $33.00, with a standard deviation of $3.56. While the lowest estimate indicates an increase of 11.1% from the current price level, ...

Aptiv PLC (APTV) closed the last trading session at $78.44, gaining 2.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $99.28 indicates a 26.6% upside potential.The mean estimate comprises 18 short-term price targets with a standard deviation of $7.07. While the lowest estimate of $84.00 indicates a 7.1% increase from the current price level, the most optimistic analyst expects t ...

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Caterpillar (CAT) .Caterpillar currently has an average brokerage recommen ...

Axsome Therapeutics (AXSM) shares rallied 22.8% in the last trading session to close at $182.64. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 4.7% gain over the past four weeks.The stock rallied after the company announced that the FDA has accepted and granted priority review to its supplemental new drug application seeking approval for AXS-05 as a treatment for Alzheimer’s disease agitation. A final decis ...

Core Viewpoint - Contineum Therapeutics, Inc. (CTNM) shows significant upside potential with a mean price target of $21.83, indicating a 91.5% increase from the current trading price of $11.4 [1] Price Targets - The average price target consists of six estimates ranging from a low of $14.00 to a high of $29.00, with a standard deviation of $4.79, suggesting variability in analyst predictions [2] - The lowest estimate indicates a potential increase of 22.8%, while the highest suggests a 154.4% upside [2] Analyst Sentiment - Analysts are optimistic about CTNM's earnings prospects, with a consensus indicating better earnings than previously estimated, which historically correlates with stock price increases [4][11] - The Zacks Consensus Estimate for the current year has increased by 1.6% due to one upward revision in estimates over the last 30 days [12] Zacks Rank - CTNM holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13] Price Movement Insights - While consensus price targets may not be entirely reliable, the direction they imply appears to be a useful guide for potential price movements [14]

Group 1 - WeRide Inc. (WRD) shares have increased by 2.7% over the past four weeks, closing at $8.9, with a mean price target of $15 indicating a potential upside of 68.5% [1] - The mean estimate consists of six short-term price targets with a standard deviation of $2.76, where the lowest estimate of $12.00 suggests a 34.8% increase, and the highest estimate of $19.00 indicates a 113.5% surge [2] - Analysts show strong agreement regarding WRD's ability to report better earnings than previously predicted, which supports the expectation of an upside [4][11] Group 2 - The Zacks Consensus Estimate for WRD's current year earnings has increased by 3.4% over the last 30 days, with one estimate moving higher and no negative revisions [12] - WRD holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating a strong potential upside [13] - While the consensus price target may not be a reliable indicator of the extent of WRD's gains, it does provide a useful guide for price movement direction [14]

Core Viewpoint - nCino (NCNO) has shown a recent price increase of 6.4% and has a mean price target of $34.73, indicating a potential upside of 32.1% from its current price of $26.29 [1] Price Targets and Analyst Estimates - The mean estimate consists of 15 short-term price targets with a standard deviation of $4.08, suggesting variability in analyst predictions. The lowest estimate is $27.00 (2.7% increase), while the highest is $41.00 (56% increase) [2] - Analysts' price targets can be misleading, as empirical research indicates that they often do not accurately predict stock price movements [7][10] - A low standard deviation among price targets indicates strong agreement among analysts regarding the stock's price direction, which can serve as a starting point for further research [9] Earnings Estimates and Analyst Sentiment - Analysts have recently revised their earnings estimates for nCino upward, with a 55.1% increase in the Zacks Consensus Estimate for the current year, reflecting strong optimism about the company's earnings prospects [11][12] - nCino holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, which supports the potential for stock upside [13] Conclusion on Price Movement - While the consensus price target may not be a reliable measure of potential gains, the direction indicated by these targets appears to be a useful guide for investors [14]

OSI Systems (OSIS) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.Since a changing ...

Group 1 - AvePoint, Inc. (AVPT) shares have increased by 5.2% over the past four weeks, closing at $13.62, with a mean price target of $20 indicating a potential upside of 46.8% [1] - The mean estimate consists of 12 short-term price targets with a standard deviation of $4.07, where the lowest estimate is $16.00 (17.5% increase) and the highest is $28.00 (105.6% increase) [2] - Analysts show strong agreement on AVPT's ability to report better earnings, with a positive trend in earnings estimate revisions correlating with potential stock upside [4][11] Group 2 - The Zacks Consensus Estimate for the current year has risen by 12% over the past month, with one estimate increasing and no negative revisions [12] - AVPT holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting exact gains, they can indicate the direction of price movement, which is useful for further research [14]